Pediatric Beta-Thalassemia Major: Chronic Transfusion, Oxidative Stress, and the Overlooked Surgical Burden
Keywords:
Beta-thalassemia major; chronic transfusion; oxidative stress; ferritin; splenectomy; pediatric surgical burdenAbstract
Association between chronic transfusion therapy, oxidative stress biomarkers, and surgicalinterventions in pediatric patients with beta-thalassemia major was evaluated in a prospectivecohort of 200 children aged 5–16 years receiving regular transfusions and chelation therapy. Serummarkers including malondialdehyde
References
Ahmed, M., & Yenzeel, W. (2021). Oxidative stress markers in pediatric beta-thalassemia major: Malondialdehyde, antioxidant enzymes, and iron overload. Pediatric Hematology Reports, 12(3), 145–152.
Al-Zahraa Sherai, F., Mabrouk, M., Badraia, I., Hagag, A., & Elaskary, E. (2025). Vascular endothelial dysfunction and oxidative stress in children with beta-thalassemia major: A quercetin intervention study. Egyptian Pediatric Association Gazette, 73, Article 9.
